Drug
Tesaglitazar clinical trials
Also written Galida.
- studies test it
- 15
- open now
- 0
- in phase 3
- 11
- first study started
- 2002
How studies write it
Studies that test it under each name
Name
Brand
Studies by the year they started
15 studies that test it; most in 2004 (7)
| Year | Studies |
|---|---|
| 2002 | 1 |
| 2004 | 7 |
| 2005 | 7 |
By phase
A phase 1/2 study counts in both.
- Phase 2
- 4
- Phase 3
- 11
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 15 · Other 0
Often tested with
Tested in the same studies.
Metformin (3) · Pioglitazone (1) · Fenofibrate (1) · Glyburide (1)
Studies
Open first, then newest update. How each study uses tesaglitazar is read from its arms, and is right about nine times in ten.
Testing it · 15
- ARMOR (Analyzing Renal Mechanisms of Creatinine Excretion in Patients On tesaglitazaR)TerminatedPhase 2AstraZenecaNCT00229684Written as Tesaglitazar
- GALLANT 6 Tesaglitazar vs. PioglitazoneTerminatedPhase 3AstraZenecaNCT00214565Written as Galida
- GALLANT 5 Tesaglitazar Versus MetforminTerminatedPhase 3AstraZenecaNCT00214591Written as GALIDA
- GALLEX 6: Study to Evaluate the Safety and Tolerability of Tesaglitazar in Patients With Type 2 Diabetes MellitusTerminatedPhase 3AstraZenecaNCT00226330Written as Tesaglitazar
- GALLEX 9: Safety and Tolerability of Oral Tesaglitazar When Added to Insulin Therapy in Patients With Type 2 DiabetesTerminatedPhase 3AstraZenecaNCT00229710Written as Tesaglitazar
- GALLANT 2 Tesaglitazar vs. PlaceboTerminatedPhase 3AstraZenecaNCT00252772Written as Tesaglitazar
- Dose Response Study in Japanese PatientsTerminatedPhase 2AstraZenecaNCT00261417Written as Tesaglitazar
- GALLANT 14 Tesaglitazar vs. Metformin and FenofibrateTerminatedPhase 3AstraZenecaNCT00261352Written as Tesaglitazar
- GALLANT 8 Tesaglitazar Add-on to MetforminTerminatedPhase 3AstraZenecaNCT00251953Written as Tesaglitazar
- GALLEX 1 - Long Term Extension Study in Patients With Type 2 DiabetesTerminatedPhase 3AstraZenecaNCT00252876Written as tesaglitazar
- ARAMIS: Actions of tesaglitazaR on fAt Metabolism and Insulin SensitivityTerminatedPhase 2AstraZenecaNCT00263965Written as Tesaglitazar
- GALLANT 4 Tesaglitazar vs. GlibenclamideTerminatedPhase 3AstraZenecaNCT00255541Written as Tesaglitazar
- GALLANT 22 Tesaglitazar vs. PlaceboTerminatedPhase 3AstraZenecaNCT00252837Written as Tesaglitazar
- GALLEX 4 - Long-Term Extension Study to Evaluate Tesaglitazar Therapy in Patients With Type 2 DiabetesTerminatedPhase 3AstraZenecaNCT00300105Written as Tesaglitazar
- GLAD: Dose-Finding, Efficacy, and Safety of AZ 242 (Tesaglitazar) in Subjects With Type 2 DiabetesCompletedPhase 2AstraZenecaNCT00280865Written as Tesaglitazar
Codes
What other systems call tesaglitazar · ClinicalTrials.gg INT004789
- MeSH (NLM) C501413tesaglitazarOne source NLM
- UNII (FDA) 6734037O3LTESAGLITAZARConfirmed FDA, NLM, Wikidata
- Wikidata Q7705411tesaglitazarConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C75985TesaglitazarOne source FDA
- DrugBank DB06536One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C501413 | tesaglitazar | One source NLM |
| UNII (FDA) | 6734037O3L | TESAGLITAZAR | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q7705411 | tesaglitazar | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C75985 | Tesaglitazar | One source FDA |
| DrugBank | DB06536 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.